Although there are already over 50 publicly traded psychedelics companies, there are dozens of privately funded companies that continue to advance the psychedelics industry. These companies have collectively raised more than $700 million from investors according to CB Insights and Neuly, with the bulk primarily invested in atai Life Sciences. Investors in these companies have…